IP Library › Assignment 011177/0854
Patent Assignment
Reel/Frame 011177/0854

Change of Name

Recorded: 2000-11-02 Pages: 4
Assignor
Assignee
AVENTIS PHARMACEUTICALS PRODUCTS INC.
EMC-G1, ROUTE 202-206; P.O. BOX 6800, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties (30)
Recombinant Dna Vector Encoding Human Endothelial Cell Growth Factor
Patent: 4,868,113 →
Application: 06/835,594 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent: 4,920,132 →
Application: 07/116,420 →
Method for the Preparation of a Theophylline Sustained Release Pharmaceutical Composition and the Composition Prepared Thereby
Patent: 5,026,709 →
Application: 07/203,435 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent: 4,920,131 →
Application: 07/209,428 →
Quinoline Derivatives and Their Use as Antagonists of Leukotriene D4
Patent: 5,059,610 →
Application: 07/477,896 →
Production of Recombinant Adeno-Associated Virus Vectors
Patent: 5,173,414 →
Application: 07/605,775 →
Compounds Having Antihypertensive and Anti-Ischemic Properties
Patent: 5,364,862 →
Application: 07/955,783 →
Production of Recombinant Adeno-Associated Virus Vectors
Patent: 5,354,678 →
Application: 07/993,776 →
Adeno-Associated Viral (Aav) Liposomes and Methods Related Thereto
Patent: 5,834,441 →
Application: 08/305,221 →
Compounds Having Antihypertensive, Cardioprotective, Anti-Ischemic and Antilipolytic Properties
Patent: 5,561,134 →
Application: 08/316,761 →
Bovine B-Endothelial Cell Growth Factor
Patent: 5,552,528 →
Application: 08/334,884 →
Compounds Having Antihypertensive, Cardioprotective, Anti-Ischemic and Antilipolytic Properties
Patent: 5,736,554 →
Application: 08/455,361 →
Adeno-Associated Viral (Aav) Liposomes and Methods Related Thereto
Patent: 5,861,171 →
Application: 08/458,342 →
Method for Producing Recombinant Adeno-Associated Virus Vectors
Patent: 5,681,731 →
Application: 08/459,049 →
Recombinant Adeno-Associated Virus Vector Packaging Cells and Methods for Use
Patent: 5,691,176 →
Application: 08/459,091 →
Recombinant Adeno-Associated Virus Vectors
Patent: 5,780,280 →
Application: 08/459,352 →
Adeno-Associated Viral (Aav) Liposomes and Methods Related Thereto
Patent: 5,861,314 →
Application: 08/471,603 →
Recombinant Human Endothelial Cell Growth Factor
Patent: 5,571,790 →
Application: 08/472,964 →
Substituted (Sulfinic Acid, Sulfonic Acid, Sulfonylamino or Sulfinylamino) N-[(Aminoiminomethyl)Phenylalkyl]-Azaheterocyclylamide Compounds
Patent: 5,612,353 →
Application: 08/481,024 →
Di[(1R)-(-)-Camphosulfonic Acid) Salt of [1S-[1ALPHA, 2BETA, 3BETA, 4ALPHA, (S*)]]-4-[7-[[2-(3-Chloro-2-Thienyl)-1-Ethylethyl]Amino]-3H- Imidazo[4,5-B]Pyridin-3-Yl]-N-Ethyl-2,3-Dihydroxycyclopentane- Carboxamide, Preparation Thereof and Use Thereof
Patent: 5,652,366 →
Application: 08/484,811 →
Recombinant Adeno-Associated Virus Vectors
Patent: 5,589,377 →
Application: 08/490,095 →
Antithrombotic Azacycloalkylalkanoyl Peptides and Pseudopeptides
Patent: 5,866,685 →
Application: 08/628,648 →
Antithrombotic Azacycloalkylalkanoyl Peptides and Pseudopeptides
Patent: 5,780,590 →
Application: 08/700,950 →
Compositions of Human Endothelial Cell Growth Factor
Patent: 5,827,826 →
Application: 08/743,261 →
Substituted Sulfonic Acid N-[(Aminoiminomethyl)Phenylalkyl]- Azaheterocyclamide Compounds
Patent: 5,731,315 →
Application: 08/761,414 →
Dna Encoding Human Endothelial Cell Growth Factors and Plasmids Comprising Said Dna
Patent: 5,849,538 →
Application: 08/840,088 →
Novel Derivatives of 2-Azabicyclo[2.2.1] Heptane, Their Prepration and Their Application
Patent: 5,912,365 →
Application: 08/914,484 →
Substituted (Sulfinic Acid, Sulfonic Acid, Sulfonylamino or Sulfinylamino) N-[(Aminoiminomethyl)Phenylalkyl]-Azaheterocyclylamide Compounds
Patent: 5,958,918 →
Application: 08/976,034 →
Substituted Sulfonic Acid N-[(Aminoiminomethyl)Phenylalkyl]-Azaheterocyclylamide Compounds
Patent: 6,034,093 →
Application: 09/130,336 →
Stereospecific Preparation of Chiral 1-Aryl-and 1-Heteroaryl-2-Substituted Ethyl-2-Amines
Patent: 6,127,550 →
Application: 09/266,641 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Mar 3, 1986
From: JAYE, MICHAEL; BURGESS, WILSON; MACIAG, THOMAS; DROHAN, WILLIAM
To: MELOY LABORATORIES INC.
Reel/Frame 004525/0699 →
Assignment of Assignors Interest. Nov 3, 1987
From: HUANG, FU-CHI; GALEMMO, ROBERT A. JR.; CAMPBELL, HENRY F.
To: RORER PHARMACEUTICAL CORPORATION, 500 VIRGINIA DRIVE, FORT WASHINGTON, PA. 19034, A DE. CORP.
Reel/Frame 004817/0239 →
Assignment of Assignors Interest. Jun 21, 1988
From: HUANG, FU-CHI; GALEMMO, ROBERT A.; CAMPBELL, HENRY F.
To: RORER PHARMACEUTICAL CORPORATION
Reel/Frame 004911/0668 →
Assignment of Assignors Interest. Apr 20, 1990
From: HUANG, FU-CHI; GALEMMO, ROBERT A. JR.; CAMPBELL, HENRY F.
To: RORER PHARMACEUTICAL CORPORATION
Reel/Frame 005341/0398 →
Assignment of Assignors Interest. May 21, 1990
From: HUANG, LIANG-LII; GRIM, WAYNE M.; LI, SHUN P.
To: WILLIAM H. RORER, INC., A CORP. OF PA.
Reel/Frame 005359/0979 →
Assignment of Assignors Interest. May 21, 1990
From: HARWOOD, RICHARD J.; MEHTA, GUNVANT N.; JHAWAR, RAMESH C.
To: WILLIAM H RORER, INC., A CORP. OF PA.
Reel/Frame 005359/0975 →
Change of Name Effective on 09/10/1990 Nov 9, 1990
From: RORER PHARMACEUTICALS INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 005563/0007 →
Assignment of Assignors Interest. Feb 4, 1991
From: LEBKOWSKI, JANE S.; OKARMA, THOMAS B.; MCNALLY, MAUREEN A.
To: APPLIED IMMUNESCIENCES, INC.
Reel/Frame 005589/0505 →
Assignment of Assignors Interest. Oct 2, 1992
From: SPADA, ALFRED PAUL; FINK, CYNTHIA ANN; MYERS, MICHAEL RAY
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 006281/0985 →
Sale / Transfer of Property Nov 16, 1992
From: RORER BIOTECHNOLOGY INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 006369/0163 →
Assignment of Assignors Interest. Mar 15, 1993
From: LEBKOWSKI, JANE
To: APPLIED IMMUNE SCIENCES, INC.
Reel/Frame 006460/0257 →
Assignment of Assignor's Interest Dec 2, 1993
From: LEBKOWSKI, JANE S.; MCNALLY, MAUREEN A.; OKARMA, THOMAS B.
To: APPLIED IMMUNE SCIENCES, INC.
Reel/Frame 006781/0712 →
Assignment of Assignor's Interest Jun 19, 1995
From: PHILIP, RAMILA; LEBKOWSKI, JANE
To: APPLIED IMMUNE SCIENCES, INC.
Reel/Frame 007523/0558 →
Assignment of Assignor's Interest Apr 4, 1996
From: OKARMA, THOMAS B.
To: APPLIED IMMUNE SCIENCES, INC.
Reel/Frame 007869/0726 →
Assignment of Assignor's Interest Apr 4, 1996
From: MCNALLY, MAUREEN A.
To: APPLIED IMMUNE SCIENCES, INC.
Reel/Frame 007869/0882 →
Assignment of Assignor's Interest Apr 4, 1996
From: LEBKOWSKI, JANE S.
To: APPLIED IMMUNE SCIENCES, INC.
Reel/Frame 007878/0072 →
Assignment of Assignor's Interest Apr 8, 1996
From: APPLIED IMMUNE SCIENCES, INC.
To: RHONE-POULENC RORER PHARMACEUTICALS, INC.
Reel/Frame 007881/0775 →
Assignment of Assignor's Interest Apr 8, 1996
From: APPLIED IMMUNE SCIENCES, INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 007885/0428 →
Assignment of Assignor's Interest Apr 8, 1996
From: APPLIED IMMUNE SCIENCES, INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 007883/0612 →
Assignment of Assignor's Interest Apr 8, 1996
From: APPLIED IMMUNE SCIENCES, INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 007883/0609 →
Assignment of Assignor's Interest Apr 8, 1996
From: INC., APPLIED IMMUNE SCIENCES
To: RHONE-POULENC RORER PHARMACEUTICAL, INC.
Reel/Frame 007885/0463 →
Assignment of Assignor's Interest Apr 8, 1996
From: APPLIED IMMUNE SCIENCES, INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 007885/0440 →
Assignment of Assignor's Interest Apr 12, 1996
From: APPLIED IMMUNE SCIENCES, INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 007891/0634 →
Assignment of Assignor's Interest Apr 12, 1996
From: APPLIED IMMUNE SCIENCES, INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 007890/0241 →
Assignment of Assignor's Interest Apr 12, 1996
From: APPLIED IMMUNE SCIENCES, INC.
To: RHONE-POULENC RORER PHARMACEUTICALS, INC.
Reel/Frame 007890/0146 →